Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
Supreme Court rejects Vanda's Hetlioz patent revival appeal
The U.S. Supreme Court has rebuffed Vanda's bid to revive patents on its 10-year-old sleep disorder drug Hetlioz following a 2023 appeals court loss.
Fraiser Kansteiner
Apr 22, 2024 3:49pm
Medincell, AbbVie set out to create new long-acting injectables
Apr 17, 2024 2:49pm
Teva CEO Richard Francis earns $25.7M thanks to welcome package
Apr 17, 2024 1:00pm
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
US shortage tally reaches all-time high, pharmacist group says
Apr 11, 2024 10:12am
Teva inks cancer biosimilar marketing pact with mAbxience
Apr 4, 2024 10:33am